Indira Das’ Post

🌐📊 Cancer Diagnostics Market Surges to USD 188.43 Billion by 2031! 📈💡 Exciting news from Cogentix Research! The cancer diagnostics market is projected to skyrocket to a staggering USD 188.43 billion by 2031, fueled by a robust 6.77% CAGR. This significant growth underscores the vital advancements and innovations in cancer diagnostics, paving the way for improved patient outcomes and enhanced healthcare solutions. Stay tuned for more insights and in-depth analysis from our expert team! #CancerDiagnostics #MarketGrowth #CogentixResearch #HealthcareInnovation #MedicalAdvancements #ResearchInsights

Could #biomarkers revolutionize cancer care? Our executive summary explores the surge in research and the road ahead. Learn more: https://ow.ly/eoTF50R15uE #cancerdetection #emergingscience #cancerawareness

https://lnkd.in/dh4GarbR Revolutionizing Cancer Care: The #ClinicalOncology Next-Generation Sequencing Market, valued at USD 9.49 Billion in 2023, anticipates a staggering growth to nearly USD 35.42 Billion by 2030, driven by a robust CAGR of 20.7%. Next-gen sequencing offers precision medicine solutions, transforming cancer diagnosis and treatment. #maximizemarketresearch #NGS #PrecisionMedicine #CancerCare #MarketGrowth

Explore the future of lung cancer diagnostics with expert insights! These short videos define essential concepts and discuss cutting-edge developments in biomarker testing. #LungCancer #Biomarkers Watch now: https://ow.ly/5nae50QOIFs

The latest IQVIA Institute for Human Data Science report https://lnkd.in/ez8wrzdv paints a stark picture of the global cancer landscape. With a dramatic rise in cancer patients projected, the pressure on the innovation ecosystem to deliver breakthrough therapies is immense. This report dives deep into cancer incidence, R&D trends, clinical development productivity, and patient access challenges. Let's discuss the implications together! Read the full report and share your thoughts in the comments. #cancer #oncology #healthcare #pharma #biotech #medicalresearch #dataanalytics

National and global collaborations, improving access to screenings, care, and treatment, and addressing social determinants of health are just some of the ways we can improve outcomes for patients and reduce the burden of cancer. At Aster Insights, we collaborate with cancer centers across the country and industry partners worldwide to advance and accelerate the development of cancer diagnostics and therapeutics. Together, we are changing the way cancer is studied, treated, and prevented.  #WorldCancerDay

The news is out! 🌟 We're thrilled to announce that we've been selected to present in an oral Minisymposium during the upcoming #AACR24 Annual Meeting. Our presentation will showcase two of our predictive PROphet® tools, which can be used independently or in combination for advanced #NSCLC patients: 1️⃣ One to guide treatment decisions by assessing a patient's probability of benefiting from immune-checkpoint inhibitor (ICI) therapy. 2️⃣ Another to assess the likelihood of patients experiencing severe immune-related adverse events (irAEs). "These findings are a source of great excitement for us, with our main commitment to bringing these advancements to healthcare providers and patients, improving cancer care globally." - Ofer Sharon, MD, CEO of OncoHost Read the full news release here: https://prn.to/4c3ZSZG Attending #AACR and want to meet? Schedule here: https://bit.ly/49VX5zF #Proteomics #CancerResearch #Biomarkers #BiomarkerDevelopment #PrecisionOncology #LCSM

Are you a Canadian cancer patient? Do you want to learn about biomarker testing? Advanced biomarker testing looks for genes, proteins, and other substances in a person's cancer (called biomarkers) to gather crucial information. These results help tailor treatment plans based on the cancer's specific characteristics, leading to personalized and often targeted precision medicine. Precision medicine is transforming cancer care, but timely and equitable access remain significant barriers. Mark your calendars for June 20th and 21st. Register for FREE here: https://lnkd.in/g8UgdsZm #CCRAN #BiomarkersConference #CancerCare #CancerCanada #CGP #Biomarkers #PrecisionMedicine

🫁November is #LungCancer Awareness month Take the time to learn more on the diagnosis & treatment of fusion-positive lung cancer from experts In this interactive case study make your own clinical decisions and see the effect they have on a patient's trajectory and disease progression 2 years later Clinical Takeaways: ✅#NGS is the main testing method to identify #NTRK fusions ✅If #IO is used as a screening method, all positive findings need to be confirmed with next generation sequencing #LCAM23 https://ow.ly/OTAO50Q6iOl

COLON CANCER: 🔍 Understanding the Landscape: Colon cancer is a formidable adversary, but with ongoing research and innovation, we're making strides in comprehending its complexities. Clinical trials play a pivotal role in this journey, providing a platform to test new treatments, medications, and therapeutic approaches. 🤝 Joining Forces: Consider this a call to action for both individuals and professionals in the healthcare sector. Participating in clinical trials not only opens doors to potential breakthroughs but also allows us to contribute directly to the advancement of medical science. It's a collaborative effort that requires the engagement of patients, caregivers, and healthcare professionals alike. #ClinicalTrials #ColonCancer #ParticipantCube